In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

Dr Vinay Prasad, an oncologist and outspoken critic of the FDA leadership and COVID-19 mandates has been named as the new ...

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

Trust in vaccine information from government health agencies has shifted along partisan lines following health agency ...

WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health leadership.

After President Trump’s first nominee to lead the Centers for Disease Control and Prevention (CDC) failed to gain traction ...

Former FDA officials have criticized the agency's new political leadership for their intervention in vaccine approvals, a process which is usually entrusted to career scientific officials.

The President Donald Trump administration’s request for Novavax Inc. NVAX to conduct new clinical trials for its COVID-19 vaccine. What Happened: Novavax announced Monday that the Food and Drug ...

He also decried “absolutism” in the vaccine ... FDA officials to add “the decision to vaccinate is a personal one” when responding to a journalist’s question about how the agency ...